See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers or a request for clarification by the drug plans.
Pharmaceutical Reviews Update 7
Published on: April 17, 2019
Result type: News